Concert Pharmaceuticals Inc. sell StockNews.com
Start price
12.03.23
/
50%
€7.88
Target price
12.03.24
-
Performance (%)
0.00%
End price
13.03.24
-
Summary
This prediction is currently being closed. StockNews_com's SELL prediction for Concert Pharmaceuticals Inc. is currently unchanged. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by StockNews_com for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CNCE provided by MarketBeat
In the thread Trading Concert Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten